NCT00602394View on ClinicalTrials.gov

Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Bipolar Disorder
Interventions
DRUG

Lithium

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, 11248 Wilcrest Green, , Houston77042, Houston

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602394 - Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions | Biotech Hunter | Biotech Hunter